AGRIS - International System for Agricultural Science and Technology

Topical sirolimus 0.1% for treating cutaneous microcystic lymphatic malformations in children and adults (TOPICAL): protocol for a multicenter phase 2, within-person, randomized, double-blind, vehicle-controlled clinical trial.

2019

Leducq, Sophie | Caille, Agnès | Barbarot, Sébastien | Beneton, Nathalie | Bessis, Didier | Boccara, Olivia | Bursztejn, Anne-Claire | Chiaverini, Christine | Dompmartin, Anne | Droitcourt, Catherine | Gissot, Valérie | Goga, Dominique | Guibaud, Laurent | Herbreteau, Denis | Le Touze, Anne | Léauté-Labrèze, Christine | Lorette, Gérard | Mallet, Stephanie | Martin, Ludovic | Mazereeuw-Hautier, Juliette | Phan, Alice | Plantin, Patrice | Quéré, Isabelle | Vabres, Pierre | Bourgoin, Helene | Giraudeau, Bruno | Maruani, Annabel | Groupe de Recherche de la Société Française de Dermatologie Pédiatrique, .


Bibliographic information
Other Subjects
Mammalian target of rapamycin inhibitor; Sirolimus; Topical rapamycin; Rapamycin; Lymphangiectasia; Vascular malformation; Cutaneous microcystic lymphatic malformation
Language
English
License
http://creativecommons.org/licenses/by/
Type
Art
Source
BioMed Central

2021-03-15
AGRIS AP